Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 864070-18-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 864070-18-8
Also known as: 864070-18-8, 4-[(5-bromo-2-chlorophenyl)methyl]phenol, Phenol, 4-[(5-bromo-2-chlorophenyl)methyl]-, Dapagliflozin impurity 39, Schembl17842, Dtxsid40726338
Molecular Formula
C13H10BrClO
Molecular Weight
297.57  g/mol
InChI Key
CSQCYSDEAYXXTN-UHFFFAOYSA-N

1 2D Structure

CAS 864070-18-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(5-bromo-2-chlorophenyl)methyl]phenol
2.1.2 InChI
InChI=1S/C13H10BrClO/c14-11-3-6-13(15)10(8-11)7-9-1-4-12(16)5-2-9/h1-6,8,16H,7H2
2.1.3 InChI Key
CSQCYSDEAYXXTN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1CC2=C(C=CC(=C2)Br)Cl)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 864070-18-8

2. 4-[(5-bromo-2-chlorophenyl)methyl]phenol

3. Phenol, 4-[(5-bromo-2-chlorophenyl)methyl]-

4. Dapagliflozin Impurity 39

5. Schembl17842

6. Dtxsid40726338

7. Amy31452

8. Mfcd19441145

9. Zinc85224782

10. 4-(5-bromo-2-chloro-benzyl)-phenol

11. Akos016008069

12. Sb17546

13. Ac-29064

14. As-10217

15. Da-22435

16. 4-[(5-bromo-2-chloro-phenyl)methyl]phenol

17. Cs-0141423

18. Ft-0718315

19. C76807

2.3 Create Date
2012-08-08
3 Chemical and Physical Properties
Molecular Weight 297.57 g/mol
Molecular Formula C13H10BrClO
XLogP34.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count2
Exact Mass295.96036 g/mol
Monoisotopic Mass295.96036 g/mol
Topological Polar Surface Area20.2 Ų
Heavy Atom Count16
Formal Charge0
Complexity216
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
864070-18-8
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY